Literature DB >> 27763625

Identification and propagation of haploid human pluripotent stem cells.

Ido Sagi1, Dieter Egli2,3, Nissim Benvenisty1.   

Abstract

Haploid human pluripotent stem cells (PSCs) integrate haploidy and pluripotency, providing a novel system for functional genomics and developmental research in humans. We have recently derived haploid human embryonic stem cells (ESCs) by parthenogenesis and demonstrated their wide differentiation potential and applicability for genetic screening. Because haploid cells can spontaneously become diploid, their enrichment at an early passage is key for successful derivation. In this protocol, we describe two methodologies, namely metaphase spread analysis and cell sorting, for the identification of haploid human cells within parthenogenetic ESC lines. The cell sorting approach also enables the isolation of haploid cells at low percentages, as well as the maintenance of highly enriched haploid ESC lines throughout passaging. The isolation of essentially pure populations of haploid human ESCs by this protocol requires basic PSC culture expertise and can be achieved within 4-6 weeks.

Entities:  

Mesh:

Year:  2016        PMID: 27763625     DOI: 10.1038/nprot.2016.145

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  39 in total

1.  Derivation of human embryonic stem cell lines from parthenogenetic blastocysts.

Authors:  Qingyun Mai; Yang Yu; Tao Li; Liu Wang; Mei-jue Chen; Shu-zhen Huang; Canquan Zhou; Qi Zhou
Journal:  Cell Res       Date:  2007-12       Impact factor: 25.617

Review 2.  RNAi screening comes of age: improved techniques and complementary approaches.

Authors:  Stephanie E Mohr; Jennifer A Smith; Caroline E Shamu; Ralph A Neumüller; Norbert Perrimon
Journal:  Nat Rev Mol Cell Biol       Date:  2014-09       Impact factor: 94.444

3.  Experimental partheonogenesis in the mouse.

Authors:  A K Tarkowski; A Witkowska; J Nowicka
Journal:  Nature       Date:  1970-04-11       Impact factor: 49.962

Review 4.  High-throughput functional genomics using CRISPR-Cas9.

Authors:  Ophir Shalem; Neville E Sanjana; Feng Zhang
Journal:  Nat Rev Genet       Date:  2015-04-09       Impact factor: 53.242

5.  Androgenetic haploid embryonic stem cells produce live transgenic mice.

Authors:  Wei Li; Ling Shuai; Haifeng Wan; Mingzhu Dong; Meng Wang; Lisi Sang; Chunjing Feng; Guan-Zheng Luo; Tianda Li; Xin Li; Libin Wang; Qin-Yuan Zheng; Chao Sheng; Hua-Jun Wu; Zhonghua Liu; Lei Liu; Liu Wang; Xiu-Jie Wang; Xiao-Yang Zhao; Qi Zhou
Journal:  Nature       Date:  2012-09-30       Impact factor: 49.962

6.  Completion of mouse embryogenesis requires both the maternal and paternal genomes.

Authors:  J McGrath; D Solter
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

Review 7.  The causes and consequences of polyploidy in normal development and cancer.

Authors:  Teresa Davoli; Titia de Lange
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-21       Impact factor: 13.827

Review 8.  Restarting life: fertilization and the transition from meiosis to mitosis.

Authors:  Dean Clift; Melina Schuh
Journal:  Nat Rev Mol Cell Biol       Date:  2013-08-14       Impact factor: 94.444

9.  Generation of haploid embryonic stem cells from Macaca fascicularis monkey parthenotes.

Authors:  Hui Yang; Zhen Liu; Yu Ma; Cuiqing Zhong; Qi Yin; Chikai Zhou; Linyu Shi; Yijun Cai; Hanzhi Zhao; Hui Wang; Fan Tang; Yan Wang; Chenchen Zhang; Xin-Yuan Liu; Dongmei Lai; Ying Jin; Qiang Sun; Jinsong Li
Journal:  Cell Res       Date:  2013-07-16       Impact factor: 25.617

10.  Genetic exploration of the exit from self-renewal using haploid embryonic stem cells.

Authors:  Martin Leeb; Sabine Dietmann; Maike Paramor; Hitoshi Niwa; Austin Smith
Journal:  Cell Stem Cell       Date:  2014-01-09       Impact factor: 24.633

View more
  1 in total

1.  Efficient SNP editing in haploid human pluripotent stem cells.

Authors:  Lauren Zakarin Safier; Michael V Zuccaro; Dietrich Egli
Journal:  J Assist Reprod Genet       Date:  2020-03-11       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.